Heme oxygenase-1 expression is down-regulated by angiotensin II and under hypertension in human neutrophils

Journal of Leukocyte Biology

Volumn 84, Issue 2, 2008, Pages 397-405

  Alba, Gonzalo ^a   El Bekay, Rajaa ^c,d   Chacón, Pedro ^a   Reyes, M Edith ^a   Ramos, Eladio ^a   Oliván, Josefina ^a   Jiménez, Juan ^a   López, José M ^b   Martín Nieto, José ^e   Pintado, Elízabeth ^a   Sobrino, Francisco ^a,f  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d Hospital University Carlos Haya de Málaga   (Spain)

^e UNIVERSITY OF ALICANTE   (Spain)

^f UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Antioxidant enzymes; Nitric oxide; Oxidative stress; Polymorphonuclear cells

Indexed keywords

ANGIOTENSIN II; HEME OXYGENASE 1; HYDRALAZINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LOSARTAN; MESSENGER RNA;

ARTICLE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HYPERTENSION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOTENSIN II; CELL CULTURE TECHNIQUES; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE-1; HUMANS; HYPERTENSION; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN D2; REFERENCE VALUES;

EID: 48649096589     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0108035     Document Type: Article

References (48)

1. Weiss, S. J. (1989) Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365-376.
2. Finkel, T. (2003) Neutrophils with a license to kill: permeabilized, not stirred. Dev. Cell 4, 146-148.
3. Parslow, R. A., Sachdev, P., Salonikas, C., Lux, O., Jorm, A. F., Naidoo, D. (2005) Associations between plasma antioxidants and hypertension in a community-based sample of 415 Australians aged 60-64. J. Hum. Hypertens. 19, 219-226.
4. Ortiz, M. C., Sanabria, E., Manriquez, M. C., Romero, J. C., Juncos, L. A. (2001) Role of endothelin and isoprostanes in slow pressor responses to angiotensin II. Hypertension 37, 505-510.
5. Paravicini, T. M., Touyz, R. M. (2006) Redox signaling in hypertension. Cardiovasc. Res. 71, 247-258.
6. Ross, R. (1999) Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-126.
7. Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., Alexander, R. W. (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74, 1141-1148.
8. Marino, F., Guasti, L., Cosentino, M., Ferrari, M., Rasini, E., Maio, R. C., Cimpanelli, M. G., Cereda, E., Crespi, C., Simoni, C., Restelli, D., Venco, A., Lecchini, S. (2007) Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. J. Cardiovasc. Pharmacol. 49, 299-305.
9. Rasini, E., Cosentino, M., Marino, F., Legnaro, M., Ferrari, M., Guasti, L., Venco, A., Lecchini, S. (2006) Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. Regul. Pept. 134, 69-74.
10. El Bekay, R., Álvarez, M., Monteseirín, J., Alba, G., Chacón, P., Vega, A., Martín-Nieto, J., Jiménez, J., Pintado, E., Bedoya, F. J., Sobrino, F. (2003) Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-κB. Blood 102, 662-671.
11. Abraham, N. G., Kappas, A. (2005) Heme oxygenase and the cardiovascular-renal system. Free Radic. Biol. Med. 39, 1-25.
12. Takahashi, T., Shimizu, H., Morimatsu, H., Inoue, K., Akagi, R., Morita, K., Sassa, S. (2007) Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev. Med. Chem. 7, 745-753.
13. 2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. J. Biol. Chem. 279, 21929-21937.
14. Levere, R. D., Martasek, P., Escalante, B., Schwartzman, M. L., Abraham, N. G. (1990) Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J. Clin. Invest. 86, 213-219.
15. Gonzales, S., Perez, M. J., Perazzo, J. C., Tomaro, M. L. (2006) Antioxidant role of heme oxygenase-1 in prehepatic portal hypertensive rats. World J. Gastroenterol. 12, 4149-4155.
16. Minamino, T., Christou, H., Hsieh, C. M., Liu, Y., Dhawan, V., Abraham, N. G., Perrella, M. A., Mitsialis, S. A., Kourembanas, S. (2001) Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc. Natl. Acad. Sci. USA 98, 8798-8803.
17. Alam, J., Stewart, D., Touchard, C., Boinapally, S., Choi, A. M., Cook, J. L. (1999) Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274, 26071-26078.
18. Ishizaka, N., de Leon, H., Laursen, J. B., Fukui, T., Wilcox, J. N., De Keulenaer, G., Griendling, K. K., Alexander, R. W. (1997) Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation 96, 1923-1929.
19. Ishizaka, N., Saito, K., Noiri, E., Sata, M., Ikeda, H., Ohno, A., Ando, J., Mori, I., Ohno, M., Nagai, R. (2005) Administration of ANG II induces iron deposition and upregulation of TGF-β1 mRNA in the rat liver. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R1063-R1070.
20. Ndisang, J. F., Wang, R. (2003) Alterations in heme oxygenase/carbon monoxide system in pulmonary arteries in hypertension. Exp. Biol. Med. (Maywood) 228, 557-563.
21. Makino, N., Suematsu, M., Sugiera, Y., Morikawa, H., Shiomi, S., Goda, N., Sano, T., Nimura, Y., Sugimachi, K., Ishimura, Y. (2001) Altered expression of heme oxygenase-1 in the livers of patients with portal hypertensive diseases. Hepatology 33, 32-42.
22. Moncada, S., Palmer, R. M., Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
23. Carballo, M., Marquez, G., Conde, M., Martín-Nieto, J., Monteseirín, J., Conde, J., Pintado, E., Sobrino, F. (1999) Characterization of calcineurin in human neutrophils. Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-κB DNA binding. J. Biol. Chem. 274, 93-100.
24. Wheeler, M. A., Smith, S. D., Garcia-Cardena, G., Nathan, C. F., Weiss, R. M., Sessa, W. C. (1997) Bacterial infection induces nitric oxide synthase in human neutrophils. J. Clin. Invest. 99, 110-116.
25. Li, M. H., Jang, J. H., Na, H. K., Cha, Y. N., Surh, Y. J. (2007) Carbon monoxide produced by heme oxygenase-1 in response to nitrosative stress induces expression of glutamate-cysteine ligase in PC12 cells via activation of phosphatidylinositol 3-kinase and Nrf2 signaling. J. Biol. Chem. 282, 28577-28586.
26. Sardana, M. K., Kappas, A. (1987) Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc. Natl. Acad. Sci. USA 84, 2464-2468.
27. Leitch, I. M., Read, M. A., Boura, A. L., Walters, W. A. (1994) Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation. Clin. Exp. Pharmacol. Physiol. 21, 615-622.
28. Polte, T., Abate, A., Dennery, P. A., Schröder, H. (2000) Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide. Arterioscler. Thromb. Vasc. Biol. 20, 1209-1215.
29. Yan, L., Vandivier, R. W., Suffredini, A. F., Danner, R. L. (1994) Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity. J. Immunol. 153, 1825-1834.
30. Chaves, F. J., Mansego, M. L., Blesa, S., Gonzalez-Albert, V., Jiménez, J., Tormos, M. C., Espinosa, O., Giner, V., Iradi, A., Saez, G., Redon, J. (2007) Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am. J. Hypertens. 20, 62-69.
31. Coles, B., Lewis, R., Anning, P. B., Morton, J., Baalasubramanian, S., Morgan, B. P., O'Donnell, V. B. (2007) CD59 or C3 are not requred for angiotensin II-dependent hypertension or hypertrophy in mice. Immunology 121, 518-525.
32. Redón, J., Oliva, M. R., Tormos, C., Giner, V., Chaves, J., Iradi, A., Sáez, G. T. (2003) Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41, 1096-1101.
33. Abraham, N. G., Asija, A., Drummond, G., Peterson, S. (2007) Heme oxygenase-1 gene therapy: recent advances and therapeutic applications. Curr. Gene Ther. 7, 89-108.
34. Olivieri, O., Lombarda, S., Russo, C., Girelli, D., Guarini, P., Carletto, A., Corrocher, R. (1998) Neutrophil arachidonic acid level and adhesive capability are increased in essential hypertension. J. Hypertens. 16, 585-592.
35. Katori, M., Busuttil, R. W., Kupiec-Weglinski, J. W. (2002) Heme oxygenase-1 system in organ transplantation. Transplantation 74, 905-912.
36. Ishizaka, N., Griendling, K. K. (1997) Heme oxygenase-1 is regulated by angiotensin II in rat vascular smooth muscle cells. Hypertension 29, 790-795.
37. Schulman, I. H., Zhou, M. S., Raij, L. (2006) Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension. J. Hypertens. Suppl. 24, S45-S50.
38. Grosser, N., Abate, A., Oberle, S., Vreman, H. J., Dennery, P. A., Becker, J. C., Pohle, T., Seidman, D. S., Schröder, H. (2003) Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem. Biophys. Res. Commun. 308, 956-960.
39. Hemmrich, K., Suschek, C. V., Lerzynski, G., Kolb-Bachofen, V. (2003) iNOS activity is essential for endothelial stress gene expression protecting against oxidative damage. J. Appl. Physiol. 95, 1937-1946.
40. Mehta, J. L., Lopez, L. M., Chen, L., Cox, O. E. (1994) Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol. Am. J. Cardiol. 74, 901-905.
41. Cheng, P. Y., Chen, J. J., Yen, M. H. (2004) The expression of heme oxygenase-1 and inducible nitric oxide synthase in aorta during the development of hypertension in spontaneously hypertensive rats. Am. J. Hypertens. 17, 1127-1134.
42. Imai, T., Morita, T., Shindo, T., Nagai, R., Yasaki, Y., Kurihara, H., Suematsu, M., Katayama, S. (2001) Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice. Circ. Res. 89, 55-62.
43. 2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-κB-p300 pathway independent of peroxisome proliferator-activated receptor γ. J. Immunol. 173, 5196-5208.
44. 2 ameliorates ischemic acute renal failure. Cardiovasc. Res. 61, 630-643.
45. Freitas, A., Alves-Filho, J. C., Secco, D. D., Neto, A. F., Ferreira, S. H., Barja-Fidalgo, C., Cunha, F. Q. (2006) Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br. J. Pharmacol. 149, 345-354.
46. Perrella, M. A., Yet, S. F. (2003) Role of heme oxygenase-1 in cardiovascular function. Curr. Pharm. Des. 9, 2479-2487.
47. Chen, Y. H., Yet, S. F., Perrella, M. A. (2003) Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function. Exp. Biol. Med. (Maywood) 228, 447-453.
48. Botros, F. T., Schwartzman, M. I., Stier Jr., C. T., Goodman, A. I., Abraham, N. G. (2005) Increase in heme oxygenase-1 levels ameliorates renovascular hypertension. Kidney Int. 68, 2745-2755.